SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Chevret Didier)
 

Search: WFRF:(Chevret Didier) > Antilymphocyte glob...

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis

Robin, Marie (author)
Hop St Louis, France
Chevret, Sylvie (author)
Univ Paris 07, France
Koster, Linda (author)
EBMT Data Off Leiden, Netherlands
show more...
Wolschke, Christine (author)
Univ Hosp Eppendorf, Germany
Yakoub-Agha, Ibrahim (author)
Univ Lille, France
Bourhis, Jean Henri (author)
Univ Paris Saclay, France
Chevallier, Patrice (author)
CHU Nantes, France
Cornelissen, Jan J. (author)
Erasmus Univ, Netherlands
Remenyi, Peter (author)
St Istvan and St Laszlo Hosp, Hungary
Maertens, Johan (author)
Univ Hosp Gasthuisberg, Belgium
Poire, Xavier (author)
Clin Univ St Luc, Belgium
Craddock, Charles (author)
Queen Elizabeth Hosp, England
Socie, Gerard (author)
Hop St Louis, France
Itala-Remes, Maija (author)
HUCH Comprehens Canc Ctr, Finland
Schouten, Harry C. (author)
Univ Hosp Maastricht, Netherlands
Marchand, Tony (author)
CHU Rennes, France
Passweg, Jakob (author)
Univ Hosp, Switzerland
Blaise, Didier (author)
Aix Marseille Univ, France
Damaj, Gandhi (author)
CHU Caen, France
Ozkurt, Zubeyde Nur (author)
Gazi Univ, Turkey
Zuckerman, Tsila (author)
Rambam Med Ctr, Israel
Cluzeau, Thomas (author)
Univ Cote Azur, France
Labussiere-Wallet, Helene (author)
Ctr Hosp Lyon Sud, France
Cammenga, Jörg (author)
Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Hematologiska kliniken US
McLornan, Donal (author)
Kings Coll London, England
Chalandon, Yves (author)
Univ Geneva, Switzerland; Univ Geneva, Switzerland
Kroger, Nicolaus (author)
EBMT Data Off Leiden, Netherlands
show less...
 (creator_code:org_t)
2019-01-17
2019
English.
In: Haematologica. - : FERRATA STORTI FOUNDATION. - 0390-6078 .- 1592-8721. ; 104:6, s. 1230-1236
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The use of antihuman T-lymphocyte immunoglobulin in the setting of transplantation from an HLA-matched related donor is still much debated. Acute and chronic graft-versus-host disease are the main causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis. The aim of this study was to evaluate the effect of antihuman T-lymphocyte immunoglobulin in a large cohort of patients with myelofibrosis (n= 287). The cumulative incidences of grade II-IV acute graft-versus-host disease among patients who were or were not given antihuman T-lymphocyte immunoglobulin were 26% and 41%, respectively. The corresponding incidences of chronic graft-versus-host disease were 52% and 55%, respectively. Non-adjusted overall survival, disease-free survival and non-relapse mortality rates were 55% versus 53%, 49% versus 45%, and 32% versus 31%, respectively, among the patients who were or were not given antihuman T-lymphocyte immunoglobulin. An adjusted model confirmed that the risk of acute graft-versus-host disease was lower following antihuman T-lymphocyte immunoglobulin (hazard ratio, 0.54; P= 0.010) while it did not decrease the risk of chronic graft-versus-host disease. The hazard ratios for overall survival and non-relapse mortality were 0.66 and 0.64, with P-values of 0.05 and 0.09, respectively. Antihuman T-lymphocyte immunoglobulin did not influence disease-free survival, graft-versus-host disease, relapse-free survival or relapse risk. In conclusion, in the setting of matched related transplantation in myelofibrosis patients, this study demonstrates that antihuman T-lymphocyte immunoglobulin decreases the risk of acute graft-versushost disease without increasing the risk of relapse.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view